Introduction
Although the incidence and mortality of gastric cancer have been decreasing, it is still the second most common cancer, next to lung cancer, around the world today [1] . Korea is an area that has one of the highest incidence rates of gastric cancer in the world, especially for men [2] . 
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Cancer statistics in Korea
According to the Seoul cancer registry data, the crude annual incidence rate of all sites of cancer per 100 000 population was 187.6 for males and 164.3 for females in 1993-1997 ( Table 1 ). The age-standardized rate for the world population was 284.0 in males and 172.3 in females.
Cancer was the third or fourth most common cause of death until the 1970s and had become the second in the 1980s. In 2000, cancer became the leading cause of death in Korea (Fig. 1) , accounting for 23.9% of all deaths in 2000 (27.5% for males and 19.4% for females). From 1990 to 2000, cerebrovascular diseases, heart diseases, and liver diseases were decreasing, but the overall cancer mortality rate increased by 9.7% [3] . The crude annual death rate of all cancers was 157.9 per 100 000 for males and 90.2 for females, and the age-standardized death rate of all cancers was 184.2 per 100 000 for males and 74.9 for females in 2000 (Table 1) .
Gastric cancer incidence in Korea
Gastric cancer is the most prevalent malignant neoplasm in Korea, comprising 20.8% of all cancer sites. For both sexes, gastric cancer is the leading malignancy, although it is less predominant in women (15.8%) than in men (24.5%) (Figs. 2, 3 ) [4] . The age-standardized incidence rate of gastric cancer was 68.1 per 100 000 for males and 29.0 per 100 000 for females annually from 1993 to 1997, as reported by the Seoul Cancer registry.
The incidence rate of gastric cancer per 100 000 per year in Korea is less than 1.0 in children and adolescents younger than age 20 years. Its incidence rate starts to rise in middle-aged adults. In men, the incidence rate of gastric cancer is doubled, with 5-year intervals, from age 45 to 60 years, and is increased by 50% with 5-year intervals thereafter. The incidence peaks in males be-tween ages 75 and 79 years; in this group, it approaches about 600 per 100 000. This trend for gastric cancer is similar in females, and its peak incidence is about 230 per 100 000 between ages 75 and 79 years. In both men and women, the incidence decreases after age 80 years. The cumulative risk of gastric cancer for the age span 0-74 years in Korea reaches 9.0% in males and 3.7% in females [5] .
In detail, the age incidence patterns by sex show a female preponderance in those under 35 years of age and reverse to a male preponderance in those over this age (Fig. 4) . This cross phenomenon of the gastric cancer incidence curve between the sexes, which was also noted among the Japanese in Osaka [6] , implies that the etiologic nature or major risk factors for gastric cancer affecting the younger age groups may be different from those affecting the older age groups. Korea and some parts of eastern Asia, including Japan, have the highest incidence of gastric cancer in the world [2]. The age incidence curves for males in Seoul, Korea; Osaka, Japan; and for white males in Los Angeles, the United States are shown in Fig. 5 . The curve for Seoul parallels that for Los Angeles; in other words, it has same the difference ratios, about 9.3-9.4, across the age groups. This parallel suggests that additional or particular factors, which are common across the age groups, are involved in the risk of gastric cancer in Korea. However, the curve for Osaka is not parallel to that for Seoul along all the age groups. In those under the age of 40 years, the incidence in Osaka is relatively reduced. This suggests that the risk of gastric cancer is changing in Japan, especially in the younger population.
Gastric cancer mortality in Korea
In Korea, the crude death rate for gastric cancer is 24.3 per 100 000, which is the second leading cause of cancer death, slightly lower than the rate for lung cancer (24.4 per 100 000). In females, gastric cancer is the leading cause of cancer death, with a crude death rate of 17.2 per 100 000, but in males, it is the third leading cause of cancer death (31.3 per 100 000), next to lung and liver cancer (36.1 and 32.5 per 100 000, respectively) [3] . The age-standardized death rate for gastric cancer in Korea is 36.7 per 100 000 in males, and 13.9 in females. ASR, Age-standardized rate degree relatives of affected individuals [8] . According to the criteria for hereditary gastric cancer presented by the International Gastric Cancer Linkage Consortium (IGCLC) in 1999, only 1% of gastric cancers meet the criteria [9] . Similarly, in Korea, the relative risk in the first-degree relatives of gastric cancer patients is 3.1, compared with the general population [10] . The ratio of hereditary gastric cancer, according to the criteria of the IGCLC, is 0.3%-3.1% of all gastric cancers [11] .
Gastric cancer is known as the second most common extracolonic cancer, next to endometrial cancer, in cases of hereditary nonpolyposis colorectal cancer (HNPCC). In Korea, the calculated risk of gastric cancer in patients with HNPCC and their first-degree relatives was 2.1-fold greater than that in the general population. In addition, the increased risk was particularly marked at a younger age; the relative risk was increased up to 11.3-fold in subjects in their thirties and 5.5-fold in those in their forties [12] .
Dietary factors are believed to be one of the most important risk factors for gastric cancer. The dietary habits of Korean people can be characterized as a high intake of salty foods and carbohydrates and a higher intake of cooked than fresh vegetables. Several casecontrol studies showed that an increased risk of gastric cancer was noted among those with a high consumption of stewed foods, such as soybean paste stew and hot pepper-soybean stew, broiled fish, and those who liked salty food. Analysis of cooking methods showed that broiling and salting increased the risk of gastric cancer, but that frying tended to decrease the risk [10, 13, 14] .
Helicobacter pylori infection has been accepted as a class I carcinogen for the development of gastric cancer, although a definite causal model does not exist. The seroprevalence of H. pylori infection in Korean adults has decreased from 80% in the 1980s to the 67% in the 1990s [15] . Previous reports from areas with a high inci- Trends in gastric cancer mortality rates by age group: Korea, 1987 Korea, -1996 As shown in Fig. 6 , the death rate for gastric cancer in Korea has been decreasing slightly over the past 20 years, although it is still high. Interestingly, this decreasing trend was marked in the middle-aged group (aged 35-64 years), but not in the older group (Fig. 7) .
Risk factors
For gastric cancer, a wide variety of etiologic risk factors, including dietary factors, chronic atrophic gastritis, intestinal metaplasia, and Helicobacter pylori infection, have been investigated. However, none of the epidemiologic factors have been sufficient to account for the pathogenesis of gastric cancer [7] .
Approximately 10% of gastric cancers show familial clustering, and case-control studies have identified a three fold increased risk of the disease in the first-dence of gastric cancer, such as Korea and China, have failed to document any relationship between H. pylori infection and gastric cancer. But, recently, one casecontrol study revealed that H. pylori infection was one of the important risk factors for the development of gastric cancer in Korea, with an odds ratio of 1.82 [16] .
Other factors contributing to the development of gastric cancer in Korea are cigarette smoking (odds ratio, 3.4) and the use of a refrigerator (odds ratio, 0.64) [10, 14] .
Pathologic features
Adenocarcinomas account for 95.8% of all gastric malignancies in Korea. The percentages of signet-ring cell carcinoma and mucinous carcinoma are 16.8% and 1.7%, respectively, in gastric adenocarcinomas [4] .
According to the recent report of the Korean Gastric Cancer Association [17] In early gastric cancer, type IIc was the most common (42.8%). The incidence of upper-one-third cancer increased slightly in 1999 (12.5%) compared with 1995 (11.2%), and this was reflected in the increased rate of proximal gastrectomy in 1999 (207 cases; 3.6%).
Treatment and results
Most gastric cancer patients in Korea receive surgery alone (42.8%) or surgery with adjuvant chemotherapy (17.4%) [4] . Operations for gastric cancer patients in 1999 were: subtotal gastrectomy (67.3%), total gastrectomy (24.1%), proximal gastrectomy (3.6%), wedge resection (0.5%), bypass surgery (1.8%), and open biopsy (2.7%) [17] .
According to the database of the Seoul National University Hospital, from 1986 to 1995, the 5-year survival rate of their 6314 patients who received operative treatment was 55.6%. According to the TNM stage, the 5-year disease-free survival rates of patients with stages Ia, Ib, II, IIIa, IIIb, and IV were 98.0%, 89.7%, 71.6%, 53.9%, 36.5%, and 23.9%, respectively (Fig. 8) .
In Korea, most surgeons perform extended lymph node dissection (D2 or D3) rather than limited lymph node dissection (D1). The number of lymph nodes resected (mean Ϯ SD) during gastrectomy in Korea was 35.9 Ϯ 18.5 in 1999, 29.4 Ϯ 16.6 in the hospitals where fewer than 100 gastrectomies were performed yearly and 41.8 Ϯ 18.3 in the hospitals where more than 500 gastrectomies were performed yearly [17] .
Regarding chemotherapy for gastric cancer, a few prospective randomized phase III trial were performed. According to a clinical trial of 5-fluorouracil (5-FU) and cisplatin (FP) versus 5-FU, doxorubicin, and mitomycin C (FAM) versus 5-FU alone (FU) in previously untreated patients with advanced gastric cancer, the FP regimen showed a significantly higher response rate than the FAM or FU regimens (51% for FP; 25% for FAM; 26% for FU), but did not show a survival benefit [18] . A few multi-institutional prospective, randomized clinical trials of adjuvant chemotherapy for gastric cancer are ongoing in Korea. Fig. 8 . Five-year disease-free survival curves after curative resection of gastric cancer according to TNM stage; database of Seoul National University Hospital (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) 
